Stay updated on Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.

Latest updates to the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page history shows a new revision label 'Revision: v3.3.3' was added, and the footer items 'HHS Vulnerability Disclosure' and the older 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page history now lists a new release entry: Revision: v3.3.2, replacing Revision: v3.3.1 in the study's version history. This is an administrative update to release notes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision history shows a new entry for v3.3.1 added and v3.2.0 removed, reflecting a minor UI/versioning update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedRemoved the site-wide government funding operating status notice from the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check57 days agoChange DetectedThe screenshots show only minor UI/layout changes to the Record History page without any edits to study data or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

Stay in the know with updates to Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.